Uranium Royalty Corporation

Uranium Royalty Corporation (NASDAQ: UROY) operates as an exploration company, which engages in acquiring and assembling a portfolio of royalties, and investing in companies with exposure to uranium and physical uranium. The company was founded by Amir Adnani on April 21, 2017 and is headquartered in Vancouver, Canada.

As per our previous Kalkine’s Global Tariff Report published on ‘UROY’ on May 04, 2026, we provided a ‘Buy’ stance on the stock at USD 3.77 based on “improving uranium market fundamentals, enhanced liquidity with cash rising to ~CAD 124 million (as of Jan 2026), and a turnaround in operating cash flow to ~CAD 36.6 million (9M FY26), coupled with a shift to profitability driven by uranium inventory monetisation and investment gains, alongside disciplined capital deployment through royalty acquisitions and portfolio recycling” and the stock price has now moved up by ~15.65% since then and has attained resistance 1 and moving towards resistance 2.

Noted below are the details of support and resistance levels provided in our previous report:

Rationales For “Sell” at Current Levels:

• Uranium Royalty Corp. Faces Limited Operating Profitability Despite Favorable Uranium Market Conditions: Uranium Royalty Corp. continues to operate with limited recurring operating profitability despite benefiting from favorable long-term uranium market fundamentals and elevated uranium prices. Although the company reported net income of CAD 5.5 million during the first nine months of fiscal 2026 compared to a loss in the prior year, profitability remains heavily dependent on uranium inventory sales, investment gains, and favorable commodity price movements rather than stable recurring royalty cash flows. Royalty revenue generation itself remained minimal, with only CAD 128,000 recognized during the nine-month period, highlighting the early-stage and non-producing nature of much of the company’s royalty portfolio.
• Heavy Reliance on Uranium Price Volatility and Inventory Trading: A significant portion of the company’s financial performance remains directly exposed to uranium price volatility and timing of physical uranium transactions. Management acknowledged that changes in quarterly profitability are largely driven by fluctuations in uranium inventory sales volumes, uranium pricing, fair value adjustments, and short-term investment performance. While the company benefited from uranium inventory sales during fiscal 2026, such gains may remain highly cyclical and difficult to sustain if uranium prices weaken or market liquidity deteriorates. The company also continues maintaining substantial physical uranium inventories valued at approximately CAD 184.9 million, exposing the balance sheet to commodity price fluctuations and inventory valuation risks.
• Development Delays and Non-Producing Royalty Exposure Remain Key Challenges: Much of Uranium Royalty Corp.’s royalty portfolio remains tied to exploration-stage, development-stage, or operationally constrained uranium projects that may take years to generate meaningful cash flow. Several underlying projects continue facing permitting, operational, production, infrastructure, and development risks. For example, Cameco disclosed production challenges at the McArthur River operation related to delayed development and workforce constraints, while the company’s Cigar Lake royalty remains subject to substantial cumulative expense recovery before meaningful royalty payments can commence. Many projects within the portfolio are still undergoing exploration, prefeasibility, or permitting activities, increasing uncertainty surrounding future royalty realization timelines.
• Equity Dilution and Dependence on External Financing Continue: The company remains dependent on external capital markets to fund acquisitions, royalty expansion initiatives, and working capital requirements. During the nine months ended January 31, 2026, Uranium Royalty Corp. issued more than 12.6 million shares under its at-the-market equity program, generating approximately CAD 74.5 million in gross proceeds. Management explicitly stated that future growth and acquisition activities may require additional equity or debt financing, while acknowledging that capital markets may not always remain receptive to new issuances on favorable terms. Continued reliance on equity financing may increase shareholder dilution risk, particularly during periods of weaker uranium market sentiment or commodity price volatility.
• Geopolitical, Regulatory, and Market Risks Continue to Impact Visibility: The uranium industry continues facing elevated geopolitical and regulatory uncertainty, particularly following the Russia-Ukraine conflict and evolving nuclear fuel supply chain policies across the United States and Europe. Although management believes these developments may support long-term uranium demand and pricing, shifting trade policies, sanctions, import restrictions, and geopolitical instability could create supply chain disruptions and increased market volatility. Additionally, many uranium development projects remain exposed to lengthy permitting timelines, environmental approvals, and changing political priorities surrounding nuclear energy development globally. As a result, the company’s long-term growth outlook remains highly sensitive to external market conditions, uranium price cycles, and broader regulatory developments within the global nuclear energy sector.

Daily Chart

Considering the company’s limited recurring royalty revenue generation, significant dependence on volatile uranium prices and physical uranium trading for profitability, continued reliance on external equity financing resulting in shareholder dilution, exposure to long development timelines and operational uncertainties across underlying uranium projects, and elevated sensitivity to geopolitical, regulatory, and commodity market risks, a ‘Sell’ rating is assigned to the ‘UROY’ at the closing market price of USD 4.36, as of May 11, 2026.

Note: This report may be updated with details around fundamental and technical analysis, price chart in due course, as appropriate.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is May 11, 2026. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level that the stock is expected to reach as per the relative valuation method and or technical analysis taking into consideration both short-term and long-term scenarios.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the New York Stock Exchange (NYSE), NASDAQ Capital Markets (NASDAQ), and or REFINITIV. Typically, all sources (NYSE, NASDAQ, or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.